Agendia Receives Fifth FDA Clearance For Industry Leading MammaPrint(R) Assay
Agendia, a world leader in molecular cancer diagnostics, announced that the company has received its fifth U.S. Food and Drug Administration (FDA) clearance for MammaPrint(R), its widely used breast cancer recurrence assay...